The document discusses approaches to deafness and rehabilitation. It defines types of hearing loss and describes various causes of sensorineural hearing loss including hereditary, infectious, inflammatory, vascular, metabolic, traumatic, degenerative and neoplastic factors. It also discusses the impact of hearing loss and methods of assessing and managing hearing loss, including hearing aids, cochlear implants, and rehabilitation programs. Early identification and intervention are emphasized for minimizing impacts on development.
Voice therapy to treat voice disorders, basics , different techniques, methods advantages and disadvantages, where and what method to choose? otorhinolaryngology ent
Voice therapy to treat voice disorders, basics , different techniques, methods advantages and disadvantages, where and what method to choose? otorhinolaryngology ent
A presentation about spasmodic dysphonia. this presentation composed of the definition, types, causes, pathophysiology, clinical feature, diagnosis, treatment and prognosis of spasmodic dysphonia.
A presentation about spasmodic dysphonia. this presentation composed of the definition, types, causes, pathophysiology, clinical feature, diagnosis, treatment and prognosis of spasmodic dysphonia.
this topic is all about deafness and hearing impairment, this is all about the classification of deafness and hearing impairment and the cause language disorder.
Hearing is the important for the development of speech and verbal communication. Impairment of hearing may be congenital or acquired.
It may be temporary or permanent, organic or inorganic, central or peripheral in origin. Hearing defect can be mild, moderate, severe or profound. It is the most common handicapped conditions in children. It is found about 9 to 15 % among Indian school children.
HEALTHCARE INITIATIVES RECOMMENDED FOR CHILDREN WITH DOWN'S SYNDROME.Dr. RIFFAT KHATTAK
"Down's Syndrome" is a condition in which a person has an extra chromosome. Chromosomes are small “packages” of genes in the body. They determine how a baby’s body forms and functions as it grows during pregnancy and after birth. Typically, a baby is born with 46 chromosomes. Babies with Down's Syndrome have an extra copy of one of these chromosomes, chromosome 21. A medical term for having an extra copy of a chromosome is ‘trisomy.’ Down's syndrome is also referred to as Trisomy 21. This extra copy changes how the baby’s body and brain develop, which can cause both mental and physical challenges for the baby.
Ear, nose, and throat (ENT) problems are common in individuals with Down’s syndrome. It is important for primary care physicians and caregivers to be aware of these problems, most of which are present throughout an individual’s life. An ENT specialist, plays an important role in the health of a person with Down’s syndrome.
ENT related problems are closely linked to physical, emotional, and educational development. Monitoring and treatment is critical, as there is a high rate of under diagnosis and under treatment of ear infections in children with Down’s Syndrome.
“Hearing Loss” that is also known as Hearing Impairment, is a problem in which a person has the inability of hearing. Dealing with any health problem can be easy if the reason for that health problem is understood at the beginning of that problem.
Hearing loss is one of the most frequent sensory deficient in human population. It affects more than 360 million people.
Consequences of hearing impairment include reduced ability to communicate, economic and educational disadvantage, social isolation and stigmatization.
we will talk also about the common types & causes of hearing loss and the possible applicable methods to treat these conditions.
Hearing is one of our primary modes of communication. 360 million people worldwide have disabling hearing loss.
Hearing loss may result from genetic causes, complications at birth, certain infectious diseases, chronic ear infections, the use of particular drugs, exposure to excessive noise and ageing.
Hearing loss may be mild, moderate, severe or profound.
It can affect one ear or both ears, and leads to difficulty in hearing conversational speech or loud sounds. it may occur in one or both ear.
CONDUCTIVE HEARING LOSS (CHL)
SENSORINEURAL HEARING LOSS (SHL)
MIXED HEARING LOSS (MHL)
Here get the information about hearing loss and the reasons of hearing loss. Know about the signs and common causes of hearing loss along with the information about hearing loss prevention.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Approch_to_Deaf_and_Mute_Child.pptx
1. Approch to Deaf and Mute Child
and its rehabilitation
Dr. Sunita Meena
Otorhinolaryngology
PIMS
2. WHODEFINATIONS
• HARD OFHEARING- hearing loss ranging from mild to severe
(>20 dBto 90dB)
• DEAF- profound hearing loss(>90dB)
• DISABLINGHEARINGLOSS- Hearing loss >40 db in the better
hearing earin adults& >30 db in the better hearing ear in
children.
9. Miscellaneous
-Meniere’s syndrome
-Bell’s palsy
-Sarcoidosis
-obscure auditory function
Sudden
Causes of sensorineural hearing loss
There are two types of causes
-Prenatal or Perinatal causes
-Postnatal causes
10.
11. PRENATAL OR PERINATAL CAUSES
Infections such as rubella, herpes, toxoplasmosis, syphilis and cytomegalovirus.
Hearing loss that runs in family.
Asphyxia or lack of oxygen at birth.
Birth weight of less than 1500 grams.
Defects of head and neck.
POSTNATAL CAUSES
Exposure to loud noise.
Bacterial Meningitis
Ototoxicity caused by exposure to drugs
Physical damage to head or ear
Hearing loss due to aging which is called as presbycusis
12. Other descriptors associated with hearing loss
Bilateral
Hearing loss in both ears.
Unilateral
Hearing loss in one ear and normal in other ear.
Symmetrical
In symmetrical hearing loss the degree and configuration are similar in both ears.
Asymmetrical
In asymmetrical hearing loss the degree and configuration are different in both ears.
Progressive versus sudden
In progressive hearing loss the loss becomes worse over time where as in sudden the
loss happens quickly.
Fluctuating versus stable
Fluctuating hearing loss changes over time, sometimes getting better sometimes
getting worse. Stable hearing loss does not change over time and remains the same
13. Hearing loss can be describe in terms of when it occurs in the process of
development of speech.
- Pre-lingual
- Post-lingual
Pre-lingual HL : Occurs where the hearing is lost before a child has completely
develop speech and language.
It may be congenital or acquired in first few year of life.
All congenital HL Is pre-lingual ,but not all pre-lingual HL is not congenital.
HL that that occurs at this stage can have a far-reaching impact on verbal and
social skill development.
Cause:
Most pre-lingual hearing impairment is due to an acquired condition , usally either
disease or trauma.
Congenital HL can be caused by genetic or non-genetic factor .
14. Non genetic factors are
-Maternal infection such as rubella ,HSV, cytomegalovirus
-Lack of oxygen
-Maternal diabetes
-Toxemia during pregnancy
-Low birth weight
-Prematurity
-Birth injuries
-Toxin Including drugs
-Alcohol consumed by mother during pregnancy
-Complication associated with the Rh factor
15. Genetic factor account for over half of the infants with congenital hearing loss.
Most of these are caused by an autosomal recessive HL.
Recent research have found 12 genes which are responsible for congenital
hearing loss.
Chromosomal disorder associated with sensorineural hearing loss include Down’s
syndrome (trisomy 21) ,trisomy 18, trisomy 13 and deletion of long arm of
chromosome 18. The hearing impairment with these disorders is predominantly
from childhood.
16. Post-lingual HL :It is more common and means the HL is acquired after speech
and language have develop (usually considered to be after 6 year of age.)
The hearing loss can still affect communication and educational development.
Adolescents who develop hearing impairment may experience social isolation,
difficulty in communicating with and being accepted by peers , and reduced
educational achievement.
A progressive deterioration of hearing is a natural part of aging process.
Typically hearing loss is gradual , and often detected by family and friends of the
people so affected long before the patients themselves.
Cause:
In some cases, the loss is extremely sudden and can be traced to specific
diseases, such as Meningitis, or ototoxic medications.
17. Ototoxic medication are
-Penicillin
-Oestrogens
-Phosphodiesterase-5 inhibitors
-Pegylated interferon
-Ribavirin
-Aminoglycosides
-Chemotherapeutic agents
Long term hearing loss is usually the product of chronic exposure to environmental
noise in industrialized countries.
Certain genetic conditions can also lead to post-lingual deafness which are
autosomal dominant.
18. Degree of hearing loss
Degree of hearing loss refers to severity of hearing loss.
According to Clark J.G. (1981) the degree of hearing loss is
classified as
Normal- -10 to 15 dBHL
Slight – 16 to 25 dBHL
Mild- 26 to 40 dBHL
Moderate- 41 to 55 dbHL
Moderately severe- 56 to 70 dBHL
Severe- 71 to 90 dBHL
Profound- 91+ dBHL
19. Impact of sensorineural hearing loss(SNHL)
Functional Impact:
One of the main impacts of hearing loss is on the individual ability to communicate
with others
Spoken language development is often delayed in children with unaddressed
hearing loss.
Unaddressed hearing loss and ear diseases such as otitis media can have a
significantly adverse effect on the academic performance of children.
Social and emotional impact:
Exclusion from communication can have a significant impact on everyday life,
causing feeling of loneliness , isolation , and frustration, particularly among older
people with HL.
Economic impact:
WHO estimates that unaddressed hearing loss poses an annual global cost of 750
billion international dollars.
20. In developing countries, children with hearing loss and deafness rarely receive any
schooling.
Adult with hearing loss also have much higher unemployment rate.
21. Management of Hearing loss
Assessment of hearing in Infants and children:
• Audiological evaluation:
-Behavioral observation audiometry
-Impedance audiometry
-Brain Stem evoked potential audiometry(BSEP)
-Auditory steady state response audiometry(ASSR)
-Oto-acoustic emission (OAE)
-Speech audiometry
• Radiological evaluation:
-CT Scan
-PET scan
-MRI
22. • Pathological evaluation: it can be
-Cochlear SNHL
-Retrocochlear SNHL
It cab differentiated by:
-Tone decay test
-Speech Audiometry (pure tone)
-Short increment sensitivity index(SISI)
-Electrocochleography
-Acoustic reflex/Stapedial reflex
-Auditory steady state response(ASSR)
-Brainstem evoked response audiometry
23. • Genetic evaluation:
- Comprehensive prenatal ,neonatal , postnatal history
-Audiometric assessment
-Three generation family history with patient history for family member with
hearing loss , sudden cardiac death, developmental delay, birth defects, common
ancestors b/w parents.
-Physical examination with particular attention to ear structure and other craniofacial
anomalies , dysmorphic features , delayed developmental milestones.
-Genetic testing: It is best carried out in setting both patient/parents are provided
pre-test & post-test genetic counselling . It can not identified 100% genetic hearing
loss.
26. Management of Hearing loss
Early detection and intervention are crucial to minimizing the impact of hearing loss
on child’s development and educational achievement.
In infants and young children with hearing loss, early identification and
management through infants hearing screening programs can improve the
linguistic and educational outcomes of child.
Children with hearing loss can benefit from:
-Rehabilitation of the Hearing impaired
-Hearing Aids
-Cochlear Implants
-Other assistive devices
-Training of child
27. Management model of audiological rehabilitation
There are four components:
- Evaluation
- Integration
- Decision making
- Short term remedial process
- On-going rehabilitation
Disability and handicap
Communication status
Associated variables
30. Hearing aids
Most deaf children have a small but useful portion of residual hearing which can be
exploited by amplification of sound.
Hearing aids should be prescribed by as early as possible. It help to develop lip
reading also.
It can be
- Directional microphone
- Body-warm device
- Spectacle aids
- In-the-ear hearing aids
- Bone conduction hearing aids
31. Cochlear implant
Surgically implanted electronic device that can help provide a sense of sound to a
person who is profoundly deaf, or severely hard of hearing.
The cochlear implant is often referred to as bionic ear.
Unlike other kinds of hearing aids the cochlear implants dose not amplify sound,
but works by directly stimulating any functioning auditory nerves inside the cochlea
with electrical impulses.
What is a Cochlear Implant?
The cochlear implant (CI) is a prosthetic replacement for the inner ear (cochlea) and is
only appropriate for people who receive minimal or no benefit from a conventional
hearing aid.
The cochlear implant bypasses damaged parts of the inner ear and electronically
stimulates the nerve of hearing.
Part of the device is surgically implanted in the skull behind the ear and tiny wires
are inserted into the cochlea.
32. Cochlear Implant History
Pre-1960’s
- beginning studies of electrical stimulation on humans.
1960’s
- active research of electrical stimulation in human ears.
1970’s
- first wearable implants designed for long-term stimulation.
1980’s
- commercial development of the cochlear implant device began.
1985
- United States Food & Drug Administration (FDA) granted the first approval for
implantation in adults.
1990
- FDA granted approval for cochlear implants in children.
Today
- cochlear implantation is a safe and effective medical procedure for
individuals who are severely to profoundly deaf with minimal benefits from
conventional hearing aids.
33. Who is a Candidate?
Candidates for implants are adults or children (12months or above ) with all of the
following:
Profound or severe hearing loss in both ears (this includes people with so-called
"nerve" deafness).
Hearing aids but receive little or no benefit from them in understanding speech by
listening alone.
Best results are obtained from those patients who good hearing at least until the
age of 6 years.
A hearing aids trial and evaluation is mandatory in determining the candidacy for
cochlear implant.
Speech and language evaluation is required to assess the child’s communicative
status and to determine any developmental language or articulation disorders.
Psychological evaluation is performed where there may be concerns regarding the
cognitive status or mental function of patient.
34. Indications for Cochlear Implantation
Criteria for Children :
-12 months or older.
-Bilateral severe-to-profound sensorineural hearing loss.
-No appreciable benefit with hearing aids after 3-6 months trial.
-Enrolled in aural/oral education program.
-No medical or anatomic contraindications.
-Motivated parents.
35. Criteria for Adult:
In adult , post-lingual sensarinural hearing loss are best candidate for cochlear
implant.
-18 years old and older (no limitation by age).
-Bilateral severe-to-profound sensorineural hearing loss (60 dB hearing loss or
greater with little or no benefit from hearing aids after 6 months trial)
-Psychologically suitable.
-No anatomic contraindications.
-Medically not contraindicated.
38. There are four basic component of cochlear implant:
-A microphone, which picks up sound from the environment.
-A speech processor, which selects and arranges sounds picked up by the
microphone.
-A transmitter and receiver/ stimulator, which receive signals from the speech
processor and convert them into electric impulses.
-And electrodes, which collect the impulses from the stimulator and send them to
the brain.
39. How Does a Cochlear Implant Work?
Sound is received by an microphone that rests over the ear like a behind-the-ear
hearing aid.
Sound is sent from the microphone to the signal processor by a thin cable.
Signal processor translates the sound into electrical codes.
Codes are sent by a thin cable to the transmitter held to the scalp by its attraction
to a magnet implanted beneath the skin.
Transmitter sends codes across the skin to a receiver/stimulator implanted in the
mastoid bone.
Receiver/stimulator converts the codes to electrical signals.
Electrical signals are sent to the specified electrodes in the array within the
cochlea to stimulate neurons.
Neurons send messages along the auditory nerve to the central auditory system in
the brain where they are interpreted as sound.
40. Surgical Procedure
Most common surgical procedure for Cochlear Implant is called Mastoidectomy
with Facial Recess Approach (MFRA). Other methods include VARIA techniques,
Trans canal approach, etc.
Overview of surgical steps:
-Skin Incision(end-aural)
-Drill Implant Bed, Electrode Channel, Suture Holes, And Mastoidectomy
-Posterior tympanotomy.
-Cochleostomy: A 1mm opening is made in front of round window into the bottom
term of cochlea .
-Inserting The Electrode Array.
-Fixation Of The Implant.
-Intraoperative mapping(NRT) is done to check electrode and its response.
-Post-op X-ray View.
41. Activation of the Device:
It is done at4 to 6 weeks after surgery.
The programming of the external speech processor is a procedure that must be
repeated one week later and then periodically thereafter.
Risks of CI Surgery:
-Injury to the facial nerve
-Post operative dizziness
-Meningitis
-Leakage of CSF
-Delayed device failure (less than 2%)
-Device migration or extrusion (rare)
42. Subject factors that might affect the performance of the Cochlear Implant:
-Etiology
-Age and Onset of Deafness
-Age at Implantation
-Residual Hearing
-Functioning auditory nerve
-For adults: Good speech, language, and communication skills
-Good motivation
-Support from family and friends
43. Postoperative Mapping (programming)of Implant & Habilitation:
Activation of implant is done 4-6 weeks after implantation. Following this the
implant is programmed or mapped.
Mapping is done on a regular basis during postoperative rehabilitation to fine-tune
the processor get the best performance as the patient gets used to hearing with
implant.
Mapping is be done by-
1 -NRT (Neural Response threshold)
-At the time of surgery
-At the time of switch on
-Postoperative as per standardized schedule
2-BOA(Behavioral Observation Audiometry)
-At the time of switch on
-Postoperative as per standardized schedule
44. 3-eESRT (electrically Evoked Auditory Stapedius Response Threshold)
- At the time of surgery
4-eEABR(electrically Evoked Auditory Brainstem Response)
5-eEACP(electrically Evoked Compound Action Potential)
45. Other Assistive Devices
Assistive Listening Devices and Systems
Alerting Devices
Telecommunicating Devices
46. Training of child
Speech Reading
Auditory Training
Speech Conservation